Your Market Research Library
 

Ask For A FREE Membership Here !
 


Your Market Research starts at Allbizreport !
Order here all your market reports, company profiles, country analysis, competitive intelligence ... upon any industries and countries :
20.000 market research, 5.000 company profiles, 150 industry monitor

   
  
   
   
   Advanced Search     

   
  
   
  
   
   


Home

Falling Margins in Pharma - increasing ROI through CRM (Market Focus)
Market Briefing, July 2007, 1516  €


Description

IntroductionThis report is an analysis of the industry drivers and inhibitors within the pharmaceutical industry that will affect the take up of CRM.ScopePharmaceutical companies are facing a multi-layered assault on their profit margins Lack of ROI to date is holding pharmaceutical companies back from investing in CRM Each region is producing differing challenges for the pharmaceutical industryHighlightsThe pharmaceutical industry is facing a number of pressures on its profit margins.
This report looks at these pressures and analysis how they are affecting the growth in the CRM.Reasons to PurchaseLearn what the key drivers are for the take up of CRM in the pharmaceutical industry are.
Understand the constraints that are holding back investment in CRM solutions.
Understand how the differences between each nations characteristics are going to affect the growth in each country.

Sommaire
 
DATAMONITOR VIEW 1
CATALYST 1
SUMMARY 1
ANALYSIS 2
Pharmaceutical companies are facing a multi-layered assault on their profit margins 2
The pharmaceutical industry is facing pressures from all sides 2
The end of an era for blockbuster drugs 3
Lack of drugs coming to market is only compounding the pharmaceutical industry's problems 4
Power to the people: fuelling the need for CRM in Pharmaceuticals 5
The patient is becoming an important influencer within the decision making process 6
The sales force has become less effective fuelling the need for a new strategy 7
Lack of ROI to date is holding pharmaceutical companies back from investing in CRM 8
Pharmaceutical companies are yet to see a ROI on their older CRM investments 9
Pharmaceutical companies do not have sufficient reference points for other CRM implementations 9
While an enterprise wide solution CRM solution is sought it can slow down the rate of implementation 9
Despite these inhibitors Datamonitor projects strong growth 10
Each region is producing differing challenges for the pharmaceutical industry 10
The US has the most consumer driven drugs market 11
Japan and Italy have cost constraints set by their governments on drug pricing 11
Pharmacoeconomics are becoming increasingly important in the UK 12
ACTIONS 13
Vendors need to use their references to help sell CRM solutions 13
The changing customer means vendors need to evolve their solutions 13
APPENDIX 14
Definitions 14
Methodology 14
Further reading 14
Ask the analyst 14
Datamonitor consulting 14
Disclaimer 15
List of Figures
Figure 1: The pharmaceutical industry is facing pressures pricing from all sides 3
Figure 2: NMEs per year vs. Global R&D spend ($billion) 1980 - 2003 4
Figure 3: How CRM can maximize sales force effectiveness 5
Figure 4: Process by which patients become more influential in drug prescription 7
Figure 5: How likely are the following factors to affect or impact your prescribing decisions? 8
Figure 6: CRM in pharmaceuticals market for Europe, North America and Japan, 2006-2012 10
Figure 7: Percentage CRM market share in pharmaceuticals, 2007 11
Figure 8: CRM in pharmaceutical market size in Italy and Japan, 2006-2012 12
[ Home ] [ Contact ] [ Site Map ]
© UBIQUICK SARL tous droits réservés